Sign Up / Log In
Account
Online Pharmacy
Doctor Services
Health Centre
Bulk Purchase
Corporate
Vilanterol is commonly used in combination with umeclidinium or fluticasone furoate to treat chronic obstructive pulmonary disease (copd)
Vilanterol is a beta 2-adrenergic agonist which is able to lead to bronchial smooth muscle relaxation and preventing the release of hypersensitivity mediators in the lungs.
Allergy reaction, Reduced blood pressure, Tachycardia, Hypokalaemia, Hyperglycaemia, Altered bowel habit, Dry mouth, Abdominal pain, Muscle ache, Headache
It is not advisable to take Vilanterol and alcohol simultaneously as alcohol may accentuate effects such as tachycardia and lowering of blood pressure.
Animal studies have shown reproductive toxicity but there are no data on the use of Vilanterol in pregnant women. Thus, Vilanterol is not advisable to be used unless the benefits outweigh the risks.
It is unknown whether Vilanterol is excreted in human milk but the other beta 2-adrenergic is known to secrete in human milk. Thus, the risk to breastfed babies cannot be excluded and a decision has to be made whether to discontinue breastfeeding or medication depending on the benefit-risk ratio.
Vilanterol usually does not affect the ability to drive. Do not drive unless you are feeling well.
Vilanterol is safe to use in patients with kidney impairment.
Vilanterol is safe to use in patients with liver impairment.